Literature DB >> 9842911

In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR/ligand density.

I Motta1, Y C Lone, P Kourilsky.   

Abstract

We previously reported that complexes of peptide with soluble single-chain recombinant MHC (SC-MHC) class I molecules are able to induce cytotoxic T lymphocytes (CTL) in vitro in a murine system with an efficiency comparable to that observed with peptide-pulsed dendritic cells as antigen-presenting cells. In this report, we have assessed the capacity of preformed peptide/SC-Kd complexes in monomeric or dimeric form as well as of peptide/SC-Kd-loaded beads to generate in vitro specific CTL responses from naive DBA/2 spleen cells. Peptide/SC-Kd-coated beads were consistently more efficient. We evaluated the role of costimulatory molecules, using monoclonal antibodies anti-CD80 or anti-CD86. In addition, the capacity of peptide/SC-Kd-coated beads to generate a CTL response from purified naive CD8+ T cells was ascertained. Taken together, the results indicate that, under our conditions, CTL priming does not require the participation of co-stimulatory molecules and is the consequence of a direct interaction between the cognate TCR on peptide-specific CTL precursors and the peptide/SC-Kd-loaded beads. Titration of the amount of preformed complexes of SC-Kd and peptide 170-179 of HLA-CW3 that need to be coated onto the beads to prime CTL precursors shows an activation threshold which can be calculated to be between 25000 and 50000 complexes. In effect, in cultures stimulated with specific peptide CW3/SC-Kd complexes representing less than 50% occupancy of the total (10(5)) complexes on the beads, no peptide-specific cytolytic activity was observed. These results suggest that the efficiency of the primary CTL induction depends on the density of specific peptide/SC-Kd complexes present on the beads.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9842911     DOI: 10.1002/(SICI)1521-4141(199811)28:11<3685::AID-IMMU3685>3.0.CO;2-3

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.

Authors:  Sonja Obermann; Susanne Petrykowska; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  Immunology       Date:  2007-04-30       Impact factor: 7.397

2.  Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Authors:  Shahram Salek-Ardakani; Ramon Arens; Rachel Flynn; Alessandro Sette; Stephen P Schoenberger; Michael Croft
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

3.  Using the TAP component of the antigen-processing machinery as a molecular adjuvant.

Authors:  Timothy Z Vitalis; Qian-Jin Zhang; Judie Alimonti; Susan S Chen; Genc Basha; Alex Moise; Jacqueline Tiong; Mei Mei Tian; Kyung Bok Choi; Douglas Waterfield; Andy Jeffries; Wilfred A Jefferies
Journal:  PLoS Pathog       Date:  2005-12-30       Impact factor: 6.823

4.  Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes.

Authors:  P Savage; P Cowburn; A Clayton; S Man; A McMichael; N Lemoine; A Epenetos; G Ogg
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

5.  Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity.

Authors:  Karlo Perica; Ang Tu; Anne Richter; Joan Glick Bieler; Michael Edidin; Jonathan P Schneck
Journal:  ACS Nano       Date:  2014-02-24       Impact factor: 15.881

6.  Nanoscale artificial antigen presenting cells for T cell immunotherapy.

Authors:  Karlo Perica; Andrés De León Medero; Malarvizhi Durai; Yen Ling Chiu; Joan Glick Bieler; Leah Sibener; Michaela Niemöller; Mario Assenmacher; Anne Richter; Michael Edidin; Mathias Oelke; Jonathan Schneck
Journal:  Nanomedicine       Date:  2013-07-24       Impact factor: 5.307

Review 7.  Linking form to function: Biophysical aspects of artificial antigen presenting cell design.

Authors:  Karlo Perica; Alyssa K Kosmides; Jonathan P Schneck
Journal:  Biochim Biophys Acta       Date:  2014-09-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.